Log transformed values for the primary and secondary outcomes
| Variable | Active | Active | Placebo | Placebo | p |
| n | mean (SD) | n | mean (SD) | ||
| hsCRP AUC (days 1–7) | 82 | 3.51 (1.42) | 78 | 3.55 (1.46) | 0.86 |
| hsCRP at day 7 | 78 | 1.03 (1.46) | 78 | 1.09 (1.91) | 0.83 |
| hsCRP at day 14 | 77 | 1.14 (1.54) | 76 | 0.89 (1.56) | 0.32 |
| hsCRP at day 30 | 76 | 1.13 (0.32) | 76 | 0.92 (1.15) | 0.30 |
| Troponin AUC (days 1–7) | 82 | 1.35 (1.88) | 78 | 1.50 (1.96) | 0.61 |
| Troponin at day 14 | 77 | −3.73 (2.31) | 76 | −4.14 (2.35) | 0.27 |
| Troponin at day 30 | 76 | −4.83 (2.44) | 76 | −4.74 (2.51) | 0.82 |
| vWF AUC (days 1–3) | 89 | 1.33 (0.35) | 84 | 1.31 (0.35) | 0.66 |
| vWF at day 14 | 77 | 0.36 (0.35) | 84 | 0.28 (0.41) | 0.23 |
| vWF at day 30 | 78 | 0.37 (0.34) | 75 | 0.29 (0.43) | 0.19 |
| IL-6 AUC (days 1–3) | 86 | 2.62 (1.13) | 83 | 2.56 (1.02) | 0.74 |
| IL-6 at day 14 | 77 | 1.32 (1.35) | 77 | 0.92 (0.75) | 0.028 |
| IL-6 at day 30 | 73 | 1.22 (0.92) | 75 | 1.08 (0.77) | 0.31 |